These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7252412)

  • 1. Inhibition of glutathione synthesis as a chemotherapeutic strategy for trypanosomiasis.
    Arrick BA; Griffith OW; Cerami A
    J Exp Med; 1981 Mar; 153(3):720-5. PubMed ID: 7252412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation.
    Hamilos DL; Wedner HJ
    J Immunol; 1985 Oct; 135(4):2740-7. PubMed ID: 4031498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical and preparative separation of the diastereomers of L-buthionine (SR)-sulfoximine, a potent inhibitor of glutathione biosynthesis.
    Campbell EB; Hayward ML; Griffith OW
    Anal Biochem; 1991 May; 194(2):268-77. PubMed ID: 1677799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of buthionine sulfoximine (NSC 326231) and its effect on melphalan-induced toxicity in mice.
    Smith AC; Liao JT; Page JG; Wientjes MG; Grieshaber CK
    Cancer Res; 1989 Oct; 49(19):5385-91. PubMed ID: 2766304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buthionine sulfoximine inhibition of cystine uptake and glutathione biosynthesis in human lung carcinoma cells.
    Brodie AE; Reed DJ
    Toxicol Appl Pharmacol; 1985 Mar; 77(3):381-7. PubMed ID: 3975906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of glutathione synthesis of Ascaris suum by buthionine sulfoximine.
    Hussein AS; Walter RD
    Parasitol Res; 1996; 82(4):372-4. PubMed ID: 8740556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione.
    Bailey HH; Mulcahy RT; Tutsch KD; Arzoomanian RZ; Alberti D; Tombes MB; Wilding G; Pomplun M; Spriggs DR
    J Clin Oncol; 1994 Jan; 12(1):194-205. PubMed ID: 8270977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of L-buthionine-[S,R]-sulfoximine on the pancreas in mice. A model of weakening glutathione-based defense mechanisms.
    Lüthen RE; Neuschwander-Tetri BA; Niederau C; Ferrell LD; Grendell JH
    Int J Pancreatol; 1994 Aug; 16(1):31-6. PubMed ID: 7528760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
    Kramer RA; Greene K; Ahmad S; Vistica DT
    Cancer Res; 1987 Mar; 47(6):1593-7. PubMed ID: 3815359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buthionine sulfoximine inhibition of glutathione biosynthesis enhances hepatic lipid peroxidation in rats during acute ethanol intoxication.
    Kera Y; Ohbora Y; Komura S
    Alcohol Alcohol; 1989; 24(6):519-24. PubMed ID: 2576368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buthionine sulfoximine-mediated depletion of glutathione in intracranial human glioma-derived xenografts.
    Skapek SX; Colvin OM; Griffith OW; Groothuis DR; Colapinto EV; Lee Y; Hilton J; Elion GB; Bigner DD; Friedman HS
    Biochem Pharmacol; 1988 Nov; 37(22):4313-7. PubMed ID: 3196356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of buthionine sulfoximine, an inhibitor of glutathione biosynthesis, on the selenium-induced lethality in mice.
    Ishikawa M; Takayanagi G; Sasaki K
    Jpn J Pharmacol; 1988 Oct; 48(2):283-6. PubMed ID: 3210451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable baseline gamma-glutamylcysteine synthetase messenger RNA expression in peripheral mononuclear cells of cancer patients, and its induction by buthionine sulfoximine treatment.
    Yao K; Godwin AK; Ozols RF; Hamilton TC; O'Dwyer PJ
    Cancer Res; 1993 Aug; 53(16):3662-6. PubMed ID: 8101766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of murine phenytoin teratogenicity by the gamma-glutamylcysteine synthetase inhibitor L-buthionine-(S,R)-sulfoximine and by the glutathione depletor diethyl maleate.
    Wong M; Helston LM; Wells PG
    Teratology; 1989 Aug; 40(2):127-41. PubMed ID: 2772848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of buthionine sulfoximine on the development of ozone-induced pulmonary fibrosis.
    Sun JD; Pickrell JA; Harkema JR; McLaughlin SI; Hahn FF; Henderson RF
    Exp Mol Pathol; 1988 Oct; 49(2):254-66. PubMed ID: 2901982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of tumour versus normal tissue glutathione by buthionine sulfoximine.
    Lee FY; Allalunis-Turner MJ; Siemann DW
    Br J Cancer; 1987 Jul; 56(1):33-8. PubMed ID: 3620316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The toxic effects, GSH depletion and radiosensitivity by BSO on retinoblastoma.
    Yi X; Ding L; Jin Y; Ni C; Wang W
    Int J Radiat Oncol Biol Phys; 1994 May; 29(2):393-6. PubMed ID: 8195039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of tumour glutathione in vivo by buthionine sulphoximine: modulation by the rate of cellular proliferation and inhibition of cancer growth.
    Terradez P; Asensi M; Lasso de la Vega MC; Puertes IR; Viña J; Estrela JM
    Biochem J; 1993 Jun; 292 ( Pt 2)(Pt 2):477-83. PubMed ID: 8503882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathione depletion by DL-buthionine-SR-sulfoximine (BSO) potentiates X-ray-induced chromosome lesions after liquid holding recovery.
    Bertsche U; Schorn H
    Radiat Res; 1986 Mar; 105(3):351-69. PubMed ID: 3754339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of buthionine sulfoximine on toxicity of verapamil and doxorubicin to multidrug resistant cells and to mice.
    Ford JM; Yang JM; Hait WN
    Cancer Res; 1991 Jan; 51(1):67-72. PubMed ID: 1988108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.